HealthyNCT00463138
Follow-up Study on Recipients of Treatment at the Jerusalem Center for the Treatment of Psychotrauma
An observational study of Healthy, run by Herzog Hospital.
Trial summary
Researchers examined perceived satisfaction and perceived increase or decrease in symptoms among recipients of treatment at the Jerusalem Center for the Treatment of Psychotrauma, using self report methods. Read more about this study
- Who is it for?
- Ages 12 years and olderHealthy volunteers can take part
- Conditions the study is for
- Healthy
- What is being tested?
- Crisis intervention
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 100 participants
- Where
- No sites listed yet
- Study dates
- Apr 2007to Mar 2008
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 years and older
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: All clients who were exposed to a traumatic event within the last 2 years and completed treatment at the Trauma Center within the last year
Who may be able to join
- All clients who were exposed to a traumatic event within the last 2 years and completed treatment at the Trauma Center within the last year
Who cannot join
- Clients under the age of 12
About this study
Researchers examined perceived satisfaction and perceived increase or decrease in symptoms among recipients of treatment at the Jerusalem Center for the Treatment of Psychotrauma, using self report methods. Researchers hypothesized that a significant number of recipients would report a decrease in their symptoms and general satisfaction with the treatment they received.
Read the detailed description
Researchers conducted a follow-up study of clients of Meytiv, the clinical branch of the Jerusalem Center for the Treatment of Psychotrauma. Researchers plan to use the results of the study to better understand the demographics of those who come to the Center, and to improve the services offered to our clients. Before beginning treatment, every Meytiv client filled out a questionnaire in which information is requested regarding demographics, trauma history, symptoms, and various levels of functioning. Researchers administered a similar self-report questionnaire to all clients upon completion of treatment. The follow-up questionnaire contained the following several indices: the Traumatic Events Screening Inventory (TESI), which requests a client's trauma history; the Multidimensional Scale of Perceived Social Support, which measures level of family, friend, and other support; the Brief Symptom Inventory, which measures level of various psychiatric symptoms, including somatic complaints, depressive symptoms, anxiety, and paranoid or hostile thoughts; the Self-Efficacy Scale, which measures level of self-reliance and confidence in one's ability to cope with stressors; and PDS, which measures subjective response to trauma, symptoms, and and level of functioning. This questionnaire, which mirrors one completed by all Meytiv's clients before treatment, was administered to those clients who completed treatment within a year of the study. Clients completed the follow-up questionnaire on condition that if they were in need of further treatment, Meytiv would refer them to the appropriate provider. Responses will be coded and analyzed to check significance among potentially related variables, including demographic variables. Most importantly, results of the follow-up questionnaire will be compared to its parallel from the beginning of treatment in order to examine what effects our treatment has on one's symptoms, and whether our clients have been satisfied
- Conditions
- Healthy
- Being tested
- Crisis intervention
- Keywords
- perceived increase or decrease in symptoms post treatment, Satisfaction with the treatment
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Crisis interventionBehavioural
What is being measured
The primary outcome is the main question the study is designed to answer.
depressive symptoms, anxiety, PDS, which measures subjective response to trauma, symptoms, and and level of functioning.
Measured: April 2007- March 2008
Secondary outcomes (1)
level of family, friend, and other support, Self-Efficacy Scale
Measured: Aprol 2007- March2008
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Apr 2007 (estimated)
- Study startApr 2007
- Primary completionMar 2008
- Study completionMar 2008
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HealthyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 100 participants (actual)
Sponsor and investigators
- Lead sponsor
- Herzog Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Dr. Ruth Pat-Horenzcyk, Herzog Hospital
- Investigators
- Danny Brom, Ph.D, Principal investigator, Israel Center for the Treatment of Psychotrauma
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00463138
- Sponsor's protocol ID
- Brom3CTIL
- Status last verified
- Sep 2013
- First submitted
- 19 Apr 2007
- Last updated
- 4 Sep 2013
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 4 Sep 2013. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Follow-up Study on Recipients of Treatment at the Jerusalem Center for the Treatment of Psychotrauma
- ClinicalTrials.gov ID
- NCT00463138
- Acronym / sponsor ID
- Brom3CTIL
- Conditions
- Healthy
- Keywords
- perceived increase or decrease in symptoms post treatment, Satisfaction with the treatment
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 100 participants (actual)
- Lead sponsor
- Herzog HospitalUniversity, hospital or other
- Study start
- Apr 2007
- Primary completion
- Mar 2008 (actual)
- Study completion
- Mar 2008 (actual)
- First posted
- 20 Apr 2007 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Researchers examined perceived satisfaction and perceived increase or decrease in symptoms among recipients of treatment at the Jerusalem Center for the Treatment of Psychotrauma, using self report methods. Researchers hypothesized that a significant number of recipients would report a decrease in their symptoms and general satisfaction with the treatment they received.
Detailed description
Researchers conducted a follow-up study of clients of Meytiv, the clinical branch of the Jerusalem Center for the Treatment of Psychotrauma. Researchers plan to use the results of the study to better understand the demographics of those who come to the Center, and to improve the services offered to our clients. Before beginning treatment, every Meytiv client filled out a questionnaire in which information is requested regarding demographics, trauma history, symptoms, and various levels of functioning. Researchers administered a similar self-report questionnaire to all clients upon completion of treatment. The follow-up questionnaire contained the following several indices: the Traumatic Events Screening Inventory (TESI), which requests a client's trauma history; the Multidimensional Scale of Perceived Social Support, which measures level of family, friend, and other support; the Brief Symptom Inventory, which measures level of various psychiatric symptoms, including somatic complaints, depressive symptoms, anxiety, and paranoid or hostile thoughts; the Self-Efficacy Scale, which measures level of self-reliance and confidence in one's ability to cope with stressors; and PDS, which measures subjective response to trauma, symptoms, and and level of functioning. This questionnaire, which mirrors one completed by all Meytiv's clients before treatment, was administered to those clients who completed treatment within a year of the study. Clients completed the follow-up questionnaire on condition that if they were in need of further treatment, Meytiv would refer them to the appropriate provider. Responses will be coded and analyzed to check significance among potentially related variables, including demographic variables. Most importantly, results of the follow-up questionnaire will be compared to its parallel from the beginning of treatment in order to examine what effects our treatment has on one's symptoms, and whether our clients have been satisfied
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 12 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- All clients who were exposed to a traumatic event within the last 2 years and completed treatment at the Trauma Center within the last year
Key inclusion criteria (1 listed)
- All clients who were exposed to a traumatic event within the last 2 years and completed treatment at the Trauma Center within the last year
Key exclusion criteria (1 listed)
- Clients under the age of 12
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Crisis intervention | Behavioural | – |
Primary outcome
depressive symptoms, anxiety, PDS, which measures subjective response to trauma, symptoms, and and level of functioning.
Time frame: April 2007- March 2008
1 secondary outcome
level of family, friend, and other support, Self-Efficacy Scale
Time frame: Aprol 2007- March2008
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Sep 2013.
Related trials for Healthy
Recruiting
THE EFFECTS OF GAME-BASED EXERCISE PROGRAMS
Physical Activity, Body Image
Not yet recruitingPhase 1
A Phase I Study of GLR2053 Tablets in Chinese Healthy Adult Participants
Atopic Dermatitis
Recruiting
Colon-delivered Riboflavin and Gut Microbiota Composition
Microbiome Dysbiosis, Gut Health
Not yet recruiting
Neuroergonomic Analysis of a Brain-Computer Interface Device (BCI)
Healthy Volunteers - Male and Female
RecruitingPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Healthy Volunteer, Atopic Dermatitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Danny Brom, Ph.D principal investigator
Israel Center for the Treatment of Psychotrauma
Questions about this trial
What is this clinical trial studying?
An observational study of Healthy, run by Herzog Hospital.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Sep 2013. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
depressive symptoms, anxiety, PDS, which measures subjective response to trauma, symptoms, and and level of functioning. (time frame: April 2007- March 2008). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Sep 2013.